Scenarios that move AMRX

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Scenarios that move AMRX: 2 analyses, 0 positive, 2 negative.

1. 2026-10-09 · Viatris to acquire Pacira for $1.65B in pain portfolio deal — ▼ · impact -20 · confidence low · horizon quarters
2. 2026-09-15 · Definium reports second Phase III success in anxiety program — ▼ · impact -13 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing